CMND – clearmind medicine inc. (US:AMEX)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

CMND

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

10/10

08:15 am

cmnd

Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site [Yahoo! Finance]

Medium Report

Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site [Yahoo! Finance]

Report

10/10

08:07 am

cmnd

Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site

Low Report

Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site

Report

9/16

04:10 pm

cmnd

Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy [Yahoo! Finance]

Low Report

Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy [Yahoo! Finance]

Report

9/16

04:06 pm

cmnd

Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy

Low Report

Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy

Report

9/12

08:20 am

cmnd

Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment

Medium Report

Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment

Report

9/6

07:55 am

cmnd

Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

Low Report

Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

Report

8/29

04:38 pm

cmnd

SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination [Yahoo! Finance]

Medium Report

SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination [Yahoo! Finance]

Report

8/29

04:25 pm

cmnd

Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment

Medium Report

Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.